advertisement
Mohamud R 10
Showing records 1 to 10 | Display all abstracts from Mohamud R100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Lambuk L; Ahmad S
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Sadikan MZ
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Ahmad S
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Nordin NA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Iezhitsa I; Agarwal R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Kadir R; Nasir NAA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V; Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Chen X; Boer J; Plebanski M; Mohamud R; Mohamud R
Frontiers in immunology 2022; 13: 857812
